(Wynnewood, PA, July 16, 2021) Lankenau Heart Institute, part of Main Line Health, has named Gianluca Torregrossa, MD, Director of Robotic Coronary Revascularization. Dr. Torregrossa is an academic cardiac surgeon dedicated to evidence-based, state-of-the-art practice in advanced coronary revascularization. Skilled in all aspects of cardiac surgery, he specializes in robotic-assisted coronary artery bypass graft (CABG) surgery and hybrid coronary revascularization in collaboration with interventional cardiology colleagues.
“We are particularly pleased to have Dr. Torregrossa join Francis Sutter, DO, FACS, at Lankenau Medical Center, which remains the nation’s busiest robotic coronary revascularization program,” says Basel Ramlawi, MD, System Chief of Cardiac Surgery, Main Line Health and co-director of the Lankenau Heart Institute. “The combined expertise of Drs. Torregrossa and Sutter in off-pump, robotic-assisted as well as traditional CABG surgery solidifies our reputation as a major referral center for patients needing coronary revascularization.”
In this newly established role, Dr. Torregrossa will continue to reinforce robotic approaches to coronary artery disease (CAD) and work to expand access to safe, effective, and durable treatment of CAD using the most appropriate and least invasive approach possible for each patient, based on new technology and research. He is dedicated to tailoring each patient’s care to minimize trauma and complications of surgery and to maximize survival and quality of life.
“We are thrilled to have Dr. Torregrossa join the cardiovascular team, and specifically the coronary program, at Main Line Health,” says Francis Sutter, DO, Chief of Cardiac Surgery, Lankenau Medical Center. “His extensive technical expertise and research background further enhance our ability to provide minimally invasive robotic-assisted coronary surgery to patients throughout the region and beyond.”
A native of Italy, Dr. Torregrossa earned his medical degree at University of Padua, where he went on to train in cardiothoracic surgery. In his final year of residency, he worked alongside retired cardiac surgeons from across Europe, treating young patients with congenital and rheumatic heart disease at Salam Centre for Cardiac Surgery in Khartoum, Sudan.
Dr. Torregrossa continued his adult cardiac surgery training in the United States with a 3-year fellowship in advanced mitral valve surgery at Mount Sinai Hospital in New York, followed by a faculty position at Mount Sinai St. Luke’s (now Mount Sinai Morningside), where he trained in several areas of advanced and robotic heart surgery, ultimately with a focus on complex, minimally invasive and robotic CABG. Dr. Torregrossa then served as Associate Director of Robotic Heart Surgery at Mount Sinai St. Luke’s before joining the section of cardiac surgery at University of Chicago Medicine. There, he was exposed to some of the most sophisticated robotic heart surgery performed in the United States and gained expertise as one of a few surgeons in the country skilled in robotic totally endoscopic coronary artery bypass (TECAB) surgery.
Dr. Torregrossa has published more than 70 peer-reviewed scientific papers in the field of cardiac surgery, is a peer reviewer for more than 5 major medical journals and serves on the editorial board of JACC Case Reports and Journal of Cardiac Surgery. He is a frequent invited speaker at national and international conferences and symposia and is highly active on social media, promoting scholarly exchange within an international community of cardiac surgeons and cardiovascular specialists on a wide variety of topics.
Founded in 1985, Main Line Health is a not-for-profit health system serving Philadelphia and its western suburbs. Main Line Health's commitment—to deliver advanced medicine for treating and curing disease, playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to be the region's premier choice for clinical care, research, and education. A team of nearly 13,000 employees and more than 2,000 physicians care for patients throughout the Main Line Health System.
At Main Line Health's core are four of the region's most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation's premier facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.
Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region's largest multispecialty physician networks.
Main Line Health is the recipient of numerous awards for quality care, and service, including U.S. News & World Report's Best Hospitals, System Magnet® designation; the nation's highest distinction for nursing excellence and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect, equity, and inclusion, has proudly received awards in this area and has embraced the American Hospital Association's #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education, and research to help patients stay healthy and live their best lives.
For more information, visit mainlinehealth.org and connect with us on social media:
The Lankenau Heart Institute is Main Line Health's premier, comprehensive cardiovascular medicine and surgery program. Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the system-wide coordination of services, Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.
Lankenau Heart Institute continues to be an innovator in the use of beating-heart techniques and robotic-assisted procedures for coronary artery revascularization, minimally invasive and transcatheter approaches for valve repair and replacement, complex aortic surgery and heart rhythm disorders. With our growing experience and focus on minimally invasive techniques, Lankenau Heart Institute has expanded participation in clinical trials year over year. Our physicians are frequently invited to participate in clinical/medical device trials, many of these designed to facilitate and expand the use of minimally invasive approaches and procedures.
With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained advance practice nurses and technologists, Lankenau Heart Institute is dedicated to managing and treating patients with simple to complex cardiovascular disease, including heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.